Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Trends News Trends In Small Cell Lung Cancer Incidence And Survival

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Trends News Trends In Small Cell Lung Cancer Incidence And Survival is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Trends News Trends In Small Cell Lung Cancer Incidence And Survival | RobinsPost News & Noticias

Oncology Adjuvants Research Report 2025: Market to Reach $2.17 Billion by 2029, Driven by Precision-, Immuno-Oncology, AI-Driven Models and Nanotechnology-Enhanced Adjuvants ...


The oncology adjuvants market is expanding due to rising cancer rates, personalized medicine demand, and advances in immuno-oncology. Opportunities include precision oncology ventures, integration of ... Read More

Imdelltra Shows Survival Benefit in Small Cell Lung Cancer


Imdelltra significantly improved progression-free and overall survival compared to chemotherapy in small cell lung cancer patients, with a median overall survival of 13.6 months versus 8.3 months. The ... Read More

Zocilurtatug Pelitecan Shows Potential in Small Cell Lung Cancer


Zocilurtatug pelitecan shows promising results as a DLL3-targeted therapy for small cell lung cancer, with high response rates and ongoing trials. Read More

New treatments worsened income-based survival disparities for lung cancer, melanoma


Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they also have worsened survival disparities between high- and low-income ... Read More

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy


Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer. Whether ... Read More

New Report: Lung Cancer Advancements Are Saving More Lives Than Ever, but Funding Cuts May Hinder Progress


American Lung Association's 'State of Lung Cancer' report reveals new national lung cancer data, calls on states to ensure access to care ... Read More

Nivolumab Plus Chemotherapy Before Surgery Improves Survival in Lung Cancer


Adding nivolumab to neoadjuvant chemotherapy significantly improved 5-year overall survival among patients with resectable non-small cell lung cancer (NSCLC), according to findings from a phase 3 ... Read More

Non-Smoker Lung Cancer Surge, Rycarza Effective for Brain Metastasis


According to the latest statistics from the Ministry of Data and Statistics, 21.9% of cancer-related deaths are attributed to lung cancer, the highest proportion. This is nearly double the rates of ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus